United States · 
Who invested in ImmunoMet?
ImmunoMet's investors include Mirae Asset Global Investments, Dr. Sung-wuk Kim and GNTech.
United States · Series B startup
Who invested in ImmunoMet
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$5.0Mraised across 1 round since 2017, from 1 source
- Latest round
- Series B, $5.0MMar 2017
- Investors
- 3
The rounds
- Mar 2017
Everyone who backed them
Dr. Sung-wuk Kimno record of our own yet1round
GNTechno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about ImmunoMet
How much has ImmunoMet raised?
ImmunoMet has raised $5.0M across 1 round since 2017.
When did ImmunoMet last raise?
ImmunoMet's most recent round was a Series B of $5.0M in Mar 2017.
What was ImmunoMet's biggest round?
Its most recent round, $5.0M in Mar 2017, is also its largest on record.
Who backed ImmunoMet first?
ImmunoMet's first round on record, in Mar 2017, was backed by Mirae Asset Global Investments, Dr. Sung-wuk Kim and GNTech.
What stage is ImmunoMet at?
ImmunoMet's latest named round is a Series B, in Mar 2017.
Where is ImmunoMet based?
ImmunoMet is based in the United States.
Companies like ImmunoMet
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.